Last updated: December 29, 2023
Sponsor: University of Milano Bicocca
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neoplasms
Inflammation
Red Blood Cell Disorders
Treatment
N/AClinical Study ID
NCT05553873
INFLA-ME
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years at the time of diagnosis of MPN Ph negative
- Diagnosis of PV, ET, PMF or post PV and post ET MF, according to current WHO orIWG-MRT criteria (diagnosis since 2000)
- Obtaining informed consent
Exclusion
Exclusion Criteria:
- Life expectancy of less than 6 months
- Accelerated phase myelofibrosis or MPN with signs of leukemic evolution
Study Design
Total Participants: 500
Study Start date:
September 08, 2022
Estimated Completion Date:
December 31, 2026
Connect with a study center
Azienda Ospedaliera Universitaria Consorziale Policlinico
Bari,
ItalyActive - Recruiting
Policlinico Sant'Orsola Malpighi
Bologna,
ItalyActive - Recruiting
ASST Spedali Civili di Brescia
Brescia,
ItalyActive - Recruiting
Policlinico Vittorio Emanuele
Catania,
ItalyActive - Recruiting
Ospedale Universitario Federico II
Napoli,
ItalyActive - Recruiting
Policlinico Umberto I, Università La Sapienza
Roma,
ItalyActive - Recruiting
Azienda Ospedaliera Universitaria Città della Salute e delle Scienza
Torino,
ItalyActive - Recruiting
Ospedale San Luigi di Orbassano - Ospedale Mauriziano
Torino,
ItalyActive - Recruiting
Azienda Ospedaliera Universitaria Friuli Centrale
Udine,
ItalyActive - Recruiting
Azienda Ospedaliera Universitaria Integrata
Verona,
ItalyActive - Recruiting
Ospedale Belcolle
Viterbo,
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.